Download MBBS (Bachelor of Medicine and Bachelor of Surgery) 4th Year (Final Year) Spotting Handwritten Notes
SPOT 1
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFINE SUPPLEMENTARY ACTION
OF PROTEINS.
Wheat.
346kcal. 11.8gm%
When combine with pulses it supplement
methionine which is deficient in pulses.
SPOT 2
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFINE SUPPLEMENTARY ACTION
OF PROTEINS.
Q.5. DEFINE PARBOILING.
Rice. 345kcal. 7gm%
4.When combine with pulses it
supplement methionine which is deficient
in pulses.
5.Partial cooking in steam.preserving the
nuteitive quality of rice .by hot soaking
process.
SPOT 3
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFICIENT AMINO ACID.
Q.5. DISEASE ASSOCIATED.DEFINE
Maize. 342kcal. 11.1gm%
4. Tryptophan and lysine
5. Pel grogenic bcoz leucine is in excess
of amount which interfere conversion of
tryptophan into niacin.
SPOT 4
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. IRON CONTENT PER 100 GRAM
Bajra (pearl mil et )
361
11.6
8
SPOT 5
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFINE SUPPLEMENTARY ACTION
OF PROTEINS.
Green gram
348
24.5
Pulses supplements threonine and lysine
which are limiting A.A. in cerals
SPOT 6
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFINE SUPPLEMENTARY ACTION
OF PROTEINS.
Bengal gram
360
17.1
Same as green gram
SPOT 7
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFINE SUPPLEMENTARY ACTION
OF PROTEINS.
Red gram
335
22.3
Same as green gram
SPOT 8
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. DEFINE SUPPLEMENTARY ACTION
OF PROTEINS.
Black gram
347
24.5
Same as green gram
SPOT 9
Q.1. IDENTIFY THE SPOT.
Q.2. CALORIE CONTENT PER 100 GRAM.
Q.3. PROTEIN CONTENT PER 100 GRAM.
Q.4. CALCIUM CONTENT PER 100 GRAM.
Soyabean
432kcal
43.2g%
240 mg
SPOT 10
Q.1. PROTEIN CONTENT PER EGG.
Q.2. ENERGY CONTENT PER EGG.
Q.3. DEFINE NPU.
Q.4. NPU FOR EGG.
1 . An egg of 60 gm= 6 gm
2 An egg of 60 gm = 70 kcal
3 product of digestibility coefficient and
biological value divided by 100.
NPU= nitrogen retained by body /
nitrogen intake ?100
4.
SPOT 11
Q.1. PROTEIN CONTENT PER 100 ML OF COW MILK.
= 3.2
Q.2. ENERGY CONTENT PER 100 ML OF COW MILK.
= 67kcal
Q.3. DIFFERENCE BETWEEN COW AND HUMAN
MILK.
Q.4. NPU FOR MILK. =. 75
A.3. cow human milk
Fat. 4.1 3.4
Protein 3.2 1.1
Lacto 4.4 7.4
Calcium 120 28
Iron 0.2. 0.4
Energy 67 65
SPOT 12
Q.1. IDENTIFY THE SPOT.
Q.2. DEFINE GLYCEMIC INDEX.
Jaggry
G.I. of a food is defined by the area under
the two hour blood glucose response
curve (AUC) fol owing ingestion of fixed
portion of test carbohydrate(usual y
50gm) as a proportion (%) of the AUC of
the std.(either glucose or white bread)
SPOT 13
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Q.4. LLINS
Q.6. IRS.
Q.7. INSECTICIDE USED IN LLIN
Q.8. INSECTICIDE USED IN IRS.
Female anopheles. Malaria & filaria(not in India) .
Residual spray (DDT, Malathion,Lindane, OMS33) ,
space spray (pyrethrum extract) , Genetic control.
Long lasting insecticidal nets
Indoor residual spray
Permethrin or Delta methrin
DDT, Malathion, Lindane, OMS-33
SPOT 14
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Q.4. LLINS
Q.6. IRS.
Q.7. INSECTICIDE USED IN LLIN
Q.8. INSECTICIDE USED IN IRS.
Female adese
Dengue,DHF, chikungunya fever, CHF, rift
val ey fever, filaria(not in India)
SPOT 15
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Head louse
Epidemic typhus, trench fever, relapsing
fever, dermatitis
Insecticidal control( 0.5%malathion,
carbaryl powder) and personal hygiene
(wash & clean hairs, clothing towels
sheets washed in hot water and soap,
steam sterilization)
SPOT 16
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Q.4. TREATMENT.
Itch mite
Scabies
Benzyl benzoate , gamma HCH (0.5to 1%)
,. Tetmosol ,. Sulphur ointment.(2.5 to
10%)
SPOT 17
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Rat flea
Bubonic plague , endemic typhus ,
chiggerosis
Insecticidal control ( DDT, gamma HCH
and dieldrin, carbaryl or diazinon).
Repel ent ( diethyltolumide ) & Rodent
control.
SPOT 18
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Hard tick
Tick typhus , viral encephalitis, viral fever ,
KFD, tularemia , tick paralysis
Insecticidal control (DDT, Lindane ,
Malathion, chlordane, dieldrin)
Environmental control ( cracks and
crevices fil ed up, animal hosts reduced)
Protection of worker
SPOT 19
Q.1. IDENTIFY THE SPOT. = Soft tick
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
Q fever, relapsing fever
Control same as hard tick
SPOT 20
Q.1. USES.
Q.2. DOSE
Q.3. MECHANISM OF ACTION.
Control of aedes
1.0ppm
Contact poison act on nervous system)
SPOT 21
Q.1. USES.
Q.2. DOSE
Q.3. MECHANISM OF ACTION.
SPOT 22
Q.1. USES.
Q.2. DOSE
Q.3. MECHANISM OF ACTION.
Rodenticide
0.75 to2% solution ( as one part with ten
part of flour)
Generate toxic phosphene gas with
gastric acid
SPOT 23
Q.1. USES.
Q.2. DOSE
Q.3. MECHANISM OF ACTION.
As a residual spray ( 1-2 g/sqm) for
antiadult mosquito control measure and
as a dust( 5 to 10% ) control of lice , ticks ,
bugs.
MOA- contact poison ( act on nervous
system )
SPOT 24
Q.1. USES.
Q.2. DOSE
Q.3. MECHANISM OF ACTION.
MOA - contact poison (AChE inhibitor)
Uses- kil ing adult mosquito to prevent
DHF and encephalitis epidemic.
Dose- 1-2 gper sq.ft.
SPOT 25
Q.1. IDENTIFY THE SPOT.
Q.2. DEFINE DISINFECTION.
Q.3. AGENT USED TO DISINFECT WATER.
Q.4. DEFINE OTA TEST.
Orthotoluidene arsenite test -
* Free and combined chlorine separately.
when orthotolidine dissolved in 10%
solution of HCl result as a reagent
formation . When this reagent added to
water containing chlorine yel ow colour is
produced instant for free and more slowly
with combined chlorine
A.3. Bleaching powder
SPOT 26
Q.1. IDENTIFY THE SPOT.
Q.2. NAME DISEASES TRANSMITTED.
Q.3. CONTROL MEASURES.
House flies
Typhoid , diarrhoea, dysentery, cholera,
gastroenteritis, amoebiasis , poliomyelitis,
conjunctivitis, trachoma , anthrax
Environmental control
Insecticidal control
Fly paper
Health education
SPOT 27
Q.1. DOSE.
Q.2. INDICATION.
Q.3. CATEGORIES OF ANIMAL BITE.
40IU/kg be
Post exposure prophylaxis asap
3 category
SPOT 28
Q.1. DOSE.
Q.2. INDICATION.
Q.3. CATEGORIES OF ANIMAL BITE.
20IU/kg
3 categories
SPOT 29
Q.1. PRIMARY WOUND MANAGEMENT OF ANIMAL
BITE.
Q.2. CATEGORISATION OF ANIMAL BITE.
Q.3. POST- EXPOSURE PROPHYLAXIS (IM)
Q.4. POST- EXPOSURE PROPHYLAXIS (ID)
Q.5. PRE- EXPOSURE PROPHYLAXIX
A.3.( 0.5 mL a) essens regimen-
0,3,7,14,28 = 5 vials 5 visits
B) zareb regimen - 0,7,21
4 vials 3 visits (2-1-1)
A.4.(0.1 ml)ID per site
0,3,7,28
2-2-2-0-2 <2 vials 4 viAl
A.5. IM 1 ml or 0.5 ml or ID of 0.1 ml volume per site
on days 0,7,and21or28.
SPOT 30
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. EXPLAIN PHENOMENON WHICH OCCURS
AFTER BCG VACCINATION.
Q.5. ADVERSE REACTION.
Q.6. DILUENT.
0.05ml til one month, 1 ml for one age ( early as
possible after birth)
ID lt upper arm
Pt suffering from.eczema , immolunodeficient,
immunosuppressive,pregnancy,
Disseminateed infection, lymphadenitis,
osteomyelitis, anaphylaxis,fever,sepsis, TSS
Normal saline
SPOT 31
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
0,6,10,14 wk
Oral two drops
same as BCG
AFP, anaphylaxis
SPOT 32
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
6,10,14 wks
0.5 ml IM antrolateral side of mid thigh
Same
Local reactions, seizures, hypotonic
hyporesponsiv episode, anaphylaxis,
encephalopathy
SPOT 33
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
three oral dose at 6,10,14 wks
Same
First dose should not be given after 12
wks of age
SPOT 35
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
SPOT 35
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
SPOT 36
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
Q.5. DILUENT.
SPOT 37
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
0.5ml , IM, 2dose 1 month gap after1 year
booster IM in upper arm
C/I - al ergy , immunocompromised pt.,
Immunosuppressive therapy ,
neurological disease
A/R - brachial neuritis , weakness ,
wasting , itiching , pain
SPOT 38
Q.1. IDENTIFY THE OBJECT.
Q.2. USES.
SPOT 39
Q.1. DOSE AND TIMING.
Q.2. SITE.
Q.3. CONTRAINDICATION.
Q.4. ADVERSE REACTION.
2,4,6,12 through 15 months
I.m.
SPOT 40
Q.1. IDENTIFY THE OBJECT.
Q.2. USES.
Q.3. DEFINE COLD CHAIN.
Q.4. DEFINE VVM.
.cold chain- a system of storage and
transport of vaccine at low temperature ,
include 6 rights (time, vaccine , quantity,
place ,condition , cost).
Vvm is a chemical indicator label
attached to the vaccine container it
records cummulative heat exposure
through gradual change in colour.
SPOT 41
Q.1. IDENTIFY THE OBJECT.
Q.2. USES.
Q.3. DEFINE COLD CHAIN.
Q.4. DEFINE VVM.
SPOT 42
Q.1. IDENTIFY THE SPOT.
Q.2. NAME ESSENTIAL FATTY ACIDS.
Q.3 CONTENT OF MUFA.
Grond nut
Oleic acid, linoleic acid, palmitic acid
41% of total f.a.
SPOT 43
Q.1. IRON AND FA CONTENT IN EACH
TABLET.
Q.2. EXPLAIN WIFS.
Q.3. RDA OF IRON FOR adolescent
100mg plus 500 microgram
Weekly for adolescent, school or at
aanganwadi, deep blue colour blisters
Prophylaxis
RDA man- 17
Women-21
Pregnant-35
Lactating-25
SPOT 44
Q.1. DOSE AND SCHEDULE.
Q.2. VITAMIN A RICH FOOD PRODUCTS.
Q.3. ASSOCIATED DISEAS
First dose one lakh at nine months,
Next doses of two lakh with a gap of six
months ( total nine doses 17 lakh)
Night blindness , xerophthalmia, corneal
xerosis , sclerosis , ulcers
SPOT 45
Q.1. IDENTIFY THE SPOT.
Q.2. DEFINE PEM. CLASSIFY PEM
ACCORDING TO SPOT.
Q.3. WHAT IS MUAC? CUT-OFF LIMIT FOR
MUAC.
SPOT 46
Q.1. INDICATIONS.
Q.2. WHAT IS RESOMAL?
Q.3. WHAT IS SUPER ORS?
Q.4. HOW DO YOU PREPARE ORS AT
HOME?
SPOT 47
Q.1. MECHANISM OF ACTION.
Q.2. FAILURE RATE.
Q.3. ADVANTAGES.
Q.4. DISADVANTAGES.
SPOT 48
Q.1. MECHANISM OF ACTION.
Q.2. DOSE SCHEDULE.
Q.3. FAILURE RATE.
Q.4. CONTRAINDICATIONS.
DMPA 150 mg every 3 months IM inj
Supperation of ovulation cervical mucus
thickning
Irregular menstrual bleeding, infertility, no
child
SPOT 49
Q.1. MECHANISM OF ACTION.
Q.2. DOSE SCHEDULE.
Q.3. FAILURE RATE.
Q.4. CONTRAINDICATIONS.
Centchromen (saheli)
Once a week pil
Take twice a week for three months, than
one tablet per week
Prevent implantation
PCOD,cervical hyperplasia, h/o jaundice,
al ergies
1.83 to 2.8
SPOT 50
Q.1. IDENTIFY THE OBJECT
Q.2. MECHANISM OF ACTION.
Q.3. TIMING OF INSERTION.
Q.4. FAILURE RATE.
Q.5. ADVERSE EFFECTS.
Q.6. CONTRAINDICATION
Cel ular and biochmical changes in endometium,
biochmical changes in mucus, inhibit sperm
motility and capicitation
0.5 to 0.8
Suspected pregnancy, vaginal bleeding ,
previous ectopic pregnancy, PID , malignancy,
Adverse effects- ectopic pregnancy, expulsion,
pelvic infection,pregnancy,mortility, pain,
bleeding
SPOT 51
Q.1. MECHANISM OF ACTION.
Q.2. DOSE SCHEDULE.
Q.3. FAILURE RATE.
Q.4. CONTRAINDICATIONS.
Q.5. ADVERSE EFFECTS.
Q.6. ADVANTAGES.
combined pil ,
Levanogesterol0.15mg,
Ethinylestradiol 0.03mg
Failure rate-zero
Prevent the release of ovum, blocking gonadotropin, cervical mucus
thickness, penetration inhibitor, motility inhibitor,sperm transport delayed
Cancer of breasts and genital, history of heart disease , hyperlipidemia,
thromboembolism, abnormal uterine bleeding , age more than 40,
smoking , htn, renal , migraine etc
CVS complications, carcinogenic, metabolic effect,liver renal disorder,
foetal Dev inhibit , weight gain ,headache , migraine ,ectopic pregnancy,
bleeding, infertility, breasts tenderness
100%effective, anxiety remove, against six disease IDA, PID,ovarian
cancer, ectopic pregnancy, fibro cystic disease
SPOT 52
Q.1. IDENTIFY THE SPOT.
Q.2. MANAGEMENT.
Q.3. RDA VITAMIN A.
RDA 600 RE in adult
950 RE. For pregnant
SPOT 53
Q.1. IDENTIFY THE SPOT.
Q.2. PREVENTION AND CONTROL
MEASURES.
Q.3. COMPLICATIONS.
- measle vaccine
-igs
-isolation, immunization of contacts,
C- otitis media , pneumonia, pulmonary
complications, neurological complications (
encephalitis,sspe),congenital abnormalities
during pregnancy , abortion, premature
delivery, def of vit A
SPOT 53
Q.1. IDENTIFY THE SPOT.
Q.2. PREVENTION AND CONTROL
MEASURES.
iodized salt , iodized oil IM inj or oral y,
Iodine monitoring, man powerminitraining ,
mass communication
SPOT 54
Q.1. IDENTIFY THE SPOT.
Q.2. ASSOCIATED DISEASE
Pel egra D , dermatitis, dementia, death ,
diarrhoea
SPOT 56
Q.1. IDENTIFY THE SPOT.
Q.2. RDA OF VITAMIN D.
Q.3. MANAGEMENT.
100 IU
education, sun bath, vit D fortified food ,
prophylaxis vit D ,60000 IU sachet
SPOT 57
Q.1. IDENTIFY THE SPOT.
Q.2. PERMISSIBLE QUANTITY OF
FLUORIDE IN DRINKING WATER.
Q.3. NALGONDA TECHNIQUE.
SPOT 58
Q.1. IDENTIFY THE SPOT.
Q.2. PERMISSIBLE QUANTITY OF
FLUORIDE IN DRINKING WATER.
Q.3. NALGONDA TECHNIQ
0.5 to 0.8 mg per ltr
Defluroridation by use of alum and lime
concentrations ( tap or drinking water and
pH dependent) single step process,in
India aandhrapradesh
SPOT 59
Q.1. IDENTIFY THE SPOT.
Q.2. PREVENTION
Q.3. LAST CASE WAS SEEN IN.......
Poliomyelitis
13 Jan 2011
IPV, OPV ,human Igs,pulse polio
immunization
This post was last modified on 11 August 2021